查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1375983

止血與組織封閉劑市場規模、佔有率、趨勢、市場分析、按產品、按地區、細分市場預測，2023-2030

Hemostasis And Tissue Sealing Agents Market Size, Share & Trends Market Analysis By Product (Topical Hemostat, Adhesive & Tissue Sealant), By Region (Europe, APAC, North America), And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

止血和組織封閉劑市場的成長和趨勢：

Grand View Research, Inc.最新報告顯示，預計到2030年，全球止血劑和組織封閉劑市場規模將達到144.7億美元，2023年至2030年年複合成長率為8.9%。

隨著時間的推移，這種藥物因其預防出血的能力而受到歡迎。微創技術的快速成長和患者對早期復原的需求預計將在預測期內推動市場成長。據美國美國1.5 億人患有至少一種可能導致手術甚至死亡的慢性疾病。

根據 CDC 估計，超過 48% 的美國人預計患有慢性病。由於手術數量不斷增加，產品需求不斷增加，預計該市場將在未來年度實現良好成長。老年人口的增加和慢性病的盛行率也是推動市場的關鍵因素之一。 2019年12月，強生公司部門Ethicon公司推出了一種止血蛋白噴霧劑，旨在快速有效地控制和封鎖微創手術和開放性手術過程中的過度出血，現已上市。

在COVID-19大大流行期間，病毒感染的重症患者往往會出現敗血性休克和急性呼吸窘迫症候群（ARDS），需要在ICU進行特殊護理，並導致慢性病，從而導致嚴重的殘疾和不良的長期結果。這些入住 ICU 的患者經常出現凝血異常，顯示潛在疾病或器官功能障礙。這是止血和組織密封產品需求不斷成長的主要因素之一。

止血和組織封閉劑市場報告亮點

  • 全球手術數量的增加以及該產品在各種手術中的適用性以避免低收縮性休克、血小板減少性疾病、輸血和術後併發症推動了市場成長。
  • 2022年，局部止血材料細分市場的銷售比重最大，為67.2%。此外，由於與常規治療結合時止血劑具有成本效益、止血劑吸收快速且容易、組織反應性極小且缺乏抗原性，止血劑將在預測期內上市。預計將在年複合成長率為9.2%。
  • 黏劑和組織密封膠領域預計在預測期內年複合成長率為 8.1%。黏劑和組織密封膠對於控制手術過程中的出血非常重要，並透過黏合和密封受損組織發揮作用。
  • 北美地區主導市場，2022 年收益佔有率最大，為 33.1%。

目錄

第1章 調查方法和範圍

第2章 執行摘要

第3章 止血劑和組織封閉劑市場變數、趨勢和範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 普及和成長前景圖
  • 產業價值鏈分析
    • 贖回框架
  • 市場動態
    • 市場促進因素分析
    • 市場抑制因素分析
  • 止血劑和組織封閉劑市場分析工具
    • 產業分析-波特五力分析
    • PESTEL分析

第4章 止血劑和組織封閉劑市場：按產品估計和趨勢分析

  • 止血與組織封閉劑市場：重點
  • 止血和組織封閉劑市場：2022 年和 2030 年趨勢和市場佔有率分析
  • 局部止血劑
  • 黏劑和組織密封劑

第5章 止血劑和組織封閉劑市場：區域估計和趨勢分析

  • 區域展望
  • 按地區分類的止血劑和組織封閉劑市場：要點
  • 北美洲
    • 2018-2030 年市場估計與預測
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 瑞典
    • 挪威
    • 丹麥
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 泰國
    • 韓國
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中東/非洲
    • 沙烏地阿拉伯
    • 南非
    • 阿拉伯聯合大公國
    • 科威特

第6章 競爭形勢

  • 主要市場參與企業的最新趨勢和影響分析
  • 市場參與企業分類
    • Johnson & Johnson
    • Artivion, Inc
    • Pfizer
    • CR Bard
    • B Braun
    • Covidien
    • Advance Medical Solutions Group
    • Smith & Nephew
Product Code: 978-1-68038-597-7

Hemostasis And Tissue Sealing Agents Market Growth & Trends:

The global hemostasis and tissue sealing agents market size is expected to reach USD 14.47 billion by 2030, registering a CAGR of 8.9% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The agents have gained popularity over time due to their ability to prevent blood loss. The rapid growth of minimally invasive technology and the demand for faster recovery by patients are expected to promote market growth over the forecast period. According to the Centers for Disease Control and Prevention (CDC), approximately 150 million of the American population are currently suffering from at least one chronic condition, which leads to surgeries and even mortality at times.

An estimate over the rising incidence was made by the CDC, which concluded that over 48% of the entire American population is expected to suffer from chronic conditions. The market is expected to witness lucrative growth over the next seven years owing to an increase in product demand supported by the rising surgery volumes. Growth in the geriatric population and the prevalence of chronic conditions are also among the key factors driving the market. In December 2019, the Ethicon, a unit of Johnson & Johnson, launched its protein spray for blood-stopping, designed to quickly & efficiently control and seal off excessive bleeding during minimally invasive procedures and open surgeries.

During the COVID-19 pandemic, severe cases among patients infected by the virus have shown the tendency to develop septic shock and Acute Respiratory Distress Syndrome (ARDS), demanding special care in ICU, with residual chronic disability and poor long-term results. Among these patients in the ICU, Coagulopathy has been commonly noticed indicating underlying diseases and organ dysfunction. This has been one of the major contributing factors to the increasing demand for hemostasis & tissue sealing products.

Hemostasis And Tissue Sealing Agents Market Report Highlights:

  • The market growth can be attributed to a rise in the global volume of surgeries and the applicability of the product across a variety of surgeries to avoid the occurrence of hypovolemic shock, thrombocytopenia, blood transfusions, and postoperative complications
  • The topical hemostat segment accounted for the largest revenue share of 67.2% in 2022. In addition, a segment is expected to grow at the fastest CAGR of 9.2% during the forecast period due to its use with conventional treatment to provide cost-efficiency, quick & easy absorbability of the hemostatic agent, minimal tissue reactivity, and non-antigenicity.
  • The adhesive & tissue sealant segment is expected to grow at a CAGR of 8.1% over the forecast period. Adhesives and tissue sealants are crucial in controlling blood loss during surgical procedures and function by binding with and sealing the damaged tissues.
  • North America dominated the market and accounted for the largest revenue share of 33.1% in 2022, owing to the growing prevalence of cardiovascular disorders, diabetes, and cancer within the region.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Material outlook
    • 2.2.3. Application outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Hemostasis & Tissue Sealing Agents Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market Driver Analysis
    • 3.4.2. Market Restraint Analysis
  • 3.5. Hemostasis & Tissue Sealing Agents Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape

Chapter 4. Hemostasis & Tissue Sealing Agents Market: Product Estimates & Trend Analysis

  • 4.1. Hemostasis & Tissue Sealing Agents Market: Key Takeaways
  • 4.2. Hemostasis & Tissue Sealing Agents Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Topical Hemostat
    • 4.3.1. Topical Hemostat market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.3.1.1. Active market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.3.2.2. Mechanical market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.3.2.3 Flowable market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. Adhesive & Tissue Sealant
    • 4.4.1. Adhesive & tissue sealant market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.1. Synthetic tissue sealant market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.2. Natural tissue sealant market estimates and forecasts, 2018 to 2030 (USD Million)
      • 4.4.1.3. Adhesion barrier products market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Hemostasis & Tissue Sealing Agents Market: Regional Estimates & Trend Analysis

  • 5.1. Regional Outlook
  • 5.2. Hemostasis & Tissue Sealing Agents Market by Region: Key Takeaway
  • 5.3. North America
    • 5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.2. U.S.
      • 5.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.3.3. Canada
      • 5.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.4. Europe
    • 5.4.1. U.K.
      • 5.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.2. Germany
      • 5.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.3. France
      • 5.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.4. Italy
      • 5.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.5. Spain
      • 5.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.6. Sweden
      • 5.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.7. Norway
      • 5.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.4.8. Denmark
      • 5.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.5. Asia Pacific
    • 5.5.1. Japan
      • 5.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.2. China
      • 5.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.3. India
      • 5.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.4. Australia
      • 5.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.5. Thailand
      • 5.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.5.6. South Korea
      • 5.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.6. Latin America
    • 5.6.1. Brazil
      • 5.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.2. Mexico
      • 5.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.6.3. Argentina
      • 5.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 5.7. MEA
    • 5.7.1. Saudi Arabia
      • 5.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.2. South Africa
      • 5.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.3. UAE
      • 5.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 5.7.4. Kuwait
      • 5.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Market Participant Categorization
    • 6.2.1. Johnson & Johnson
      • 6.2.1.1. Company overview
      • 6.2.1.2. Financial performance
      • 6.2.1.3. Product benchmarking
      • 6.2.1.4. Strategic initiatives
    • 6.2.2. Artivion, Inc
      • 6.2.2.1. Company overview
      • 6.2.2.2. Financial performance
      • 6.2.2.3. Product benchmarking
      • 6.2.2.4. Strategic initiatives
    • 6.2.3. Pfizer
      • 6.2.3.1. Company overview
      • 6.2.3.2. Financial performance
      • 6.2.3.3. Product benchmarking
      • 6.2.3.4. Strategic initiatives
    • 6.2.4. C R Bard
      • 6.2.4.1. Company overview
      • 6.2.4.2. Financial performance
      • 6.2.4.3. Product benchmarking
      • 6.2.4.4. Strategic initiatives
    • 6.2.5. B Braun
      • 6.2.5.1. Company overview
      • 6.2.5.2. Financial performance
      • 6.2.5.3. Product benchmarking
      • 6.2.5.4. Strategic initiatives
    • 6.2.6. Covidien
      • 6.2.6.1. Company overview
      • 6.2.6.2. Financial performance
      • 6.2.6.3. Product benchmarking
      • 6.2.6.4. Strategic initiatives
    • 6.2.7. Advance Medical Solutions Group
      • 6.2.7.1. Company overview
      • 6.2.7.2. Financial performance
      • 6.2.7.3. Product benchmarking
      • 6.2.7.4. Strategic initiatives
    • 6.2.8. Smith & Nephew
      • 6.2.8.1. Company overview
      • 6.2.8.2. Financial performance
      • 6.2.8.3. Product benchmarking
      • 6.2.8.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 North America hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 3 North America hemostasis & tissue sealing agents market, by region, 2018 - 2030 (USD Million)
  • Table 4 U.S. hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 5 Canada hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 6 Europe hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 7 Europe hemostasis & tissue sealing agents market, by region, 2018 - 2030 (USD Million)
  • Table 8 Germany hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 9 UK hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 10 France hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 11 Italy hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 12 Spain hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 13 Sweden hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 14 Norway hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 15 Denmark hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 16 Asia Pacific hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 17 Asia Pacific hemostasis & tissue sealing agents market, by region, 2018 - 2030 (USD Million)
  • Table 18 China hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 19 Japan hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 20 India hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 21 Australia hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 22 Thailand hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 23 South Korea hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 24 Latin America hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 25 Latin America hemostasis & tissue sealing agents market, by region, 2018 - 2030 (USD Million)
  • Table 26 Brazil hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 27 Mexico hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 28 Argentina hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 29 Middle East and Africa hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 30 Middle East and Africa hemostasis & tissue sealing agents market, by region, 2018 - 2030 (USD Million)
  • Table 31 South Africa hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 32 Saudi Arabia hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 33 UAE hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)
  • Table 34 Kuwait hemostasis & tissue sealing agents market, by product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Hemostasis & tissue sealing agents: Market outlook
  • Fig. 9 Hemostasis & tissue sealing agents: Competitive insights
  • Fig. 10 Parent market outlook
  • Fig. 11 Related/ancillary market outlook
  • Fig. 12 Penetration and growth prospect mapping
  • Fig. 13 Industry value chain analysis
  • Fig. 14 Hemostasis & tissue sealing agents market driver impact
  • Fig. 15 Hemostasis & tissue sealing agents market restraint impact
  • Fig. 16 Hemostasis & Tissue Sealing Agents Market Strategic Initiatives Analysis
  • Fig. 17 Hemostasis & tissue sealing agents market: Product movement analysis
  • Fig. 18 Hemostasis & tissue sealing agents market: Product outlook and key takeaways
  • Fig. 19 Topical hemostat market estimates and forecasts, 2018 - 2030
  • Fig. 20 Active market estimates and forecasts, 2018 - 2030
  • Fig. 21 Mechanical market estimates and forecasts, 2018 - 2030
  • Fig. 22 Flowable market estimates and forecasts, 2018 - 2030
  • Fig. 23 Adhesives & tissue sealant market estimates and forecasts, 2018 - 2030
  • Fig. 24 Synthetic tissue sealant market estimates and forecasts, 2018 - 2030
  • Fig. 25 Natural tissue sealant market estimates and forecasts, 2018 - 2030
  • Fig. 26 Adhesion barrier products market estimates and forecasts, 2018 - 2030
  • Fig. 27 Global Hemostasis & tissue sealing agents market: Regional movement analysis
  • Fig. 28 Global Hemostasis & tissue sealing agents market: Regional outlook and key takeaways
  • Fig. 29 North America market estimates and forecasts, 2018 - 2030
  • Fig. 30 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 31 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 32 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 33 U.K. market estimates and forecasts, 2018 - 2030
  • Fig. 34 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 35 France market estimates and forecasts, 2018 - 2030
  • Fig. 36 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 37 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 38 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 39 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 40 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 41 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 42 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 43 China market estimates and forecasts, 2018 - 2030
  • Fig. 44 India market estimates and forecasts, 2018 - 2030
  • Fig. 45 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 46 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 47 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 48 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 49 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 50 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 51 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 52 Middle East and Africa. market estimates and forecasts, 2018 - 2030
  • Fig. 53 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 54 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 55 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 56 Kuwait market estimates and forecasts, 2018 - 2030